Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0143 Transporter Info
Gene Name	SLC22A17
Transporter Name	Brain-type organic cation transporter
Gene ID	51310
UniProt ID	Q8WUG5

Post-Translational Modification of This DT
Overview of SLC22A17 Modification Sites with Functional and Structural Information
Sequence	M A S D P I F T L A P P L H C H Y G A F P P N A S G W E Q P P N A S G V S V A S A A L A A S A A S R V A T S T D P S C S G F A P P D F N H C L K D W D Y N G L P V L T T N A I G Q W D L V C D L G W Q V I L E Q I L F I L G F A S G Y L F L G Y P A D R F G R R G I V L L T L G L V G P C G V G G A A A G S S T G V M A L R F L L G F L L A G V D L G V Y L M R L E L C D P T Q R L R V A L A G E L V G V G G H F L F L G L A L V S K D W R F L Q R M I T A P C I L F L F Y G W P G L F L E S A R W L I V K R Q I E E A Q S V L R I L A E R N R P H G Q M L G E E A Q E A L Q D L E N T C P L P A T S S F S F A S L L N Y R N I W K N L L I L G F T N F I A H A I R H C Y Q P V G G G G S P S D F Y L C S L L A S G T A A L A C V F L G V T V D R F G R R G I L L L S M T L T G I A S L V L L G L W D C E H P I F P T V W A Q Q G N P N R D L N E A A I T T F S V L G L F S S Q A A A I L S T L L A A E V I P T T V R G R G L G L I M A L G A L G G L S G P A Q R L H M G H G A F L Q H V V L A A C A L L C I L S I M L L P E T K R K L L P E V L R D G E L C R R P S L L R Q P P P T R C D H V P L L A T P N P A L
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A17			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC22A17 Asparagine 23 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC22A17			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC22A17 Asparagine 32 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A17			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	180
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC22A17 Cystine 180 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC22A17			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	511
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC22A17 Cystine 511 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A17			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	150
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A17 Serine 150 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC22A17			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	151
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A17 Serine 151 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC22A17			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A17 Serine 515 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC22A17			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	134
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A17 Threonine 134 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC22A17			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	152
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A17 Threonine 152 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC22A17			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	533
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC22A17 Threonine 533 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S22AH_HUMAN)
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
4	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
5	Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
6	Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence